(Q37079127)

18 August 2017

1 reference

title

Sildenafil: a review of its use in pulmonary arterial hypertension (English)

1 reference

18 August 2017

main subject

arterial hypertension

0 references

2

Monique P Curran

1 reference

18 August 2017

Katherine F Croom

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

68

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

383-397

1 reference

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200868030-00009

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200868030-00009

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

12 December 2020

Sildenafil for pulmonary arterial hypertension associated with connective tissue disease

1 reference

12 December 2020

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study

1 reference

12 December 2020

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

12 December 2020

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

1 reference

12 December 2020

In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions

1 reference

12 December 2020

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

1 reference

12 December 2020

Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension: current therapeutic strategies

1 reference

12 December 2020

Pulmonary arterial hypertension

1 reference

12 December 2020

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension

1 reference

12 December 2020

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

12 December 2020

A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension

1 reference

12 December 2020

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

1 reference

12 December 2020

Effects of grapefruit juice on the pharmacokinetics of sildenafil

1 reference

12 December 2020

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

12 December 2020

Pharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years

1 reference

12 December 2020

An evidence-based approach to the management of pulmonary arterial hypertension

1 reference

12 December 2020

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension

1 reference

12 December 2020

Expert opinion on available options treating pulmonary arterial hypertension

1 reference

12 December 2020

Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil

1 reference

12 December 2020

Ambrisentan, a non-peptide endothelin receptor antagonist

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension

1 reference

12 December 2020

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

12 December 2020

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

1 reference

12 December 2020

Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

1 reference

12 December 2020

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil

1 reference

12 December 2020

Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil

1 reference

12 December 2020

Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man

1 reference

12 December 2020

The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension

1 reference

12 December 2020

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study

1 reference

12 December 2020

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

1 reference

12 December 2020

Pulmonary arterial hypertension in France: results from a national registry

1 reference

12 December 2020

An epidemiological study of pulmonary arterial hypertension.

1 reference

12 December 2020

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence

1 reference

12 December 2020

Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension

1 reference

12 December 2020

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

1 reference

12 December 2020

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality

1 reference

12 December 2020

Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension

1 reference

12 December 2020

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

12 December 2020

10.2165/00003495-200868030-00009

Identifiers

DOI

1 reference

18 August 2017

1 reference